secwatch.observer — SEC 8-K summary
======================================

Issuer:     ATHERSYS, INC / NEW (—)
CIK:        0001368148
Form:       8-K
Filed at:   2022-12-29T23:59:59+00:00
Accession:  0001368148-22-000162
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Athersys receives Nasdaq bid-price deficiency notice; 180 days to cure
----------------------------------------------------------------------

- Nasdaq notified Athersys on Dec 22, 2022 that bid price was below $1.00 for 30 consecutive business days.
- Company has until June 20, 2023 to regain compliance by closing at or above $1.00 for 10 consecutive days.
- Common stock continues trading on Nasdaq Capital Market during the cure period.
- Options include a potential reverse stock split; risk of delisting if not cured or extended.
- Failure to regain compliance may lead to delisting, with a possible appeal to Nasdaq Hearings Panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1368148/000136814822000162/0001368148-22-000162-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1368148/000136814822000162/athx-20221222.htm
  HTML page:      https://secwatch.observer/filing/0001368148-22-000162

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer